{"nctId":"NCT00662831","briefTitle":"Study Of The Effect Of Fragmin In The Treatment Of Neuroischaemic Foot Ulcers In Diabetic Patients","startDateStruct":{"date":"2008-04"},"conditions":["Diabetic Foot Ulcer"],"count":276,"armGroups":[{"label":"Active","type":"EXPERIMENTAL","interventionNames":["Drug: Fragmin/ Dalteparin Sodium"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo for Fragmin/ Dalteparin Sodium"]}],"interventions":[{"name":"Fragmin/ Dalteparin Sodium","otherNames":[]},{"name":"Placebo for Fragmin/ Dalteparin Sodium","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Male or female subjects 18 years of age with type 1 or type 2 diabetes.\n* Subjects with peripheral occlusive arterial disease (PAOD) and a neuropathy disability score (NDS) of \\>3\n\nExclusion Criteria:\n\n* Subjects who have undergone vascular reconstruction or angioplasty less than 1 month prior to randomization. Subjects with an ulcer grading of 0 or 3 and staging of A, B or D according to the University of Texas wound classification system.\n* Subjects with a known bleeding disorder or evidence of active bleeding.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Participants With Greater Than or Equal to 50 Percent Reduction in Ulcer Surface Area Including Intact Skin Healing","description":"University of Texas (UT) system assesses ulcer depth, wound infection and clinical signs of lower-extremity ischemia. UT Wound Classification (1C/2C) was based on grade (0= healed site to 3= penetrating wound to bone or joint) and stage (A= clean wounds to D= ischaemic infected wounds) of wounds. Participants were evaluated at 4 stratums: Stratum 1: Toe pressure\\>30 mm of mercury (mmHg) and UT grade and stage 1C. Stratum 2: Toe pressure\\<=30 mmHg and UT grade and stage 1C. Stratum 3: Toe pressure\\>30 mmHg and UT grade and stage 2C. Stratum 4: Toe pressure\\<=30 mmHg and UT grade and stage 2C.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"68","spread":null},{"groupId":"OG001","value":"31","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"23","spread":null},{"groupId":"OG001","value":"14","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"21","spread":null},{"groupId":"OG001","value":"10","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"9","spread":null},{"groupId":"OG001","value":"6","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Intact Skin Healing","description":"Intact skin healing was defined as 100 percent reduction in ulcer surface area with full epithelialisation. UT system assesses ulcer depth, wound infection and clinical signs of lower-extremity ischemia. Participants were evaluated at 4 stratums: Stratum 1: Toe pressure\\>30 mm of mercury (mmHg) and UT grade and stage 1C. Stratum 2: Toe pressure\\<=30 mmHg and UT grade and stage 1C. Stratum 3: Toe pressure\\>30 mmHg and UT grade and stage 2C. Stratum 4: Toe pressure\\<=30 mmHg and UT grade and stage 2C.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"35","spread":null},{"groupId":"OG001","value":"16","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"15","spread":null},{"groupId":"OG001","value":"4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8","spread":null},{"groupId":"OG001","value":"4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"4","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants Who Underwent Any Amputation","description":"Any amputation included both major and minor amputations. A major amputation was defined as above the ankle and was reported as below-the-knee and above-the-knee amputations. A minor amputation was defined as below the ankle amputation.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8","spread":null},{"groupId":"OG001","value":"2","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants Who Underwent Major and Minor Amputation","description":"A major amputation was defined as above the ankle and was reported as below-the-knee and above-the-knee amputations. A minor amputation was defined as below the ankle amputation.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Greater Than or Equal to 50 Percent Reduction in Ulcer Surface Area Excluding Intact Skin Healing","description":"University of Texas (UT) system assesses ulcer depth, wound infection and clinical signs of lower-extremity ischemia. UT Wound Classification (1C/2C) was based on grade (0= healed site to 3= penetrating wound to bone or joint) and stage (A= clean wounds to D= ischaemic infected wounds) of wounds. Participants were evaluated at 4 stratums: Stratum 1: Toe pressure\\>30 mm of mercury (mmHg) and UT grade and stage 1C. Stratum 2: Toe pressure\\<=30 mmHg and UT grade and stage 1C. Stratum 3: Toe pressure\\>30 mmHg and UT grade and stage 2C. Stratum 4: Toe pressure\\<=30 mmHg and UT grade and stage 2C.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"33","spread":null},{"groupId":"OG001","value":"15","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8","spread":null},{"groupId":"OG001","value":"10","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"13","spread":null},{"groupId":"OG001","value":"6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8","spread":null},{"groupId":"OG001","value":"2","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants Who Died","description":null,"paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4","spread":null},{"groupId":"OG001","value":"3","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Major Cardiovascular Disease Events (MCVE)","description":"Major cardiovascular events were defined as death due to vascular cause; non-fatal myocardial infarction (MI) excluding procedure related to MI; coronary revascularization procedures not related to MIs; hospitalization for unstable angina or non-fatal stroke.","paramType":null,"dispersionType":null,"classes":[]},{"type":"SECONDARY","title":"Time to Intact Skin Healing","description":"Median time taken to achieve intact skin healing which was defined as 100 percent reduction in ulcer surface area with full epithelialisation.","paramType":null,"dispersionType":null,"classes":[]},{"type":"SECONDARY","title":"Median Time to First Amputation","description":null,"paramType":null,"dispersionType":null,"classes":[]},{"type":"SECONDARY","title":"Euro Quality of Life-5 Dimensions (EQ-5D)- Utility Score","description":"EQ-5D: participant rated questionnaire to assess health-related quality of life in terms of a single utility score. It assesses level of current health for 5 domains: mobility, self-care, usual activities, pain and discomfort, and anxiety and depression; 1 indicates better health state (no problems); 3 indicates worst health state (eg, \"confined to bed\"). Scoring formula developed by EuroQol Group assigns a utility value for each domain in profile. Score is transformed and results in a total score range -0.594 to 1.000; higher score indicates a better health state.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.60","spread":"0.26"},{"groupId":"OG001","value":"0.60","spread":"0.30"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.70","spread":"0.22"},{"groupId":"OG001","value":"0.60","spread":"0.33"}]}]}]},{"type":"SECONDARY","title":"Euro Quality of Life (EQ-5D)- Visual Analog Scale (VAS)","description":"EQ-5D: participant rated questionnaire to assess health-related quality of life in terms of a single index value. The VAS component rates current health state on a scale from 0 mm (worst imaginable health state) to 100 mm (best imaginable health state); higher scores indicate a better health state.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"60.20","spread":"18.68"},{"groupId":"OG001","value":"55.30","spread":"19.72"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"63.30","spread":"18.76"},{"groupId":"OG001","value":"60.70","spread":"18.02"}]}]}]},{"type":"SECONDARY","title":"36-Item Short-Form Health Survey (SF-36) Score","description":"SF-36 is a standardized survey evaluating 8 aspects of functional health and well being: physical and social functioning, physical and emotional role limitations, bodily pain, general health, vitality, mental health. The score for a section is an average of the individual question scores, which are scaled 0-100 (100=highest level of functioning).","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"34.70","spread":"12.06"},{"groupId":"OG001","value":"32.50","spread":"10.96"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"35.40","spread":"11.22"},{"groupId":"OG001","value":"35.20","spread":"11.41"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"42.30","spread":"11.19"},{"groupId":"OG001","value":"40.30","spread":"11.52"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"42.30","spread":"5.52"},{"groupId":"OG001","value":"42.60","spread":"5.10"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"48.30","spread":"5.63"},{"groupId":"OG001","value":"48.70","spread":"5.02"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"33.00","spread":"6.49"},{"groupId":"OG001","value":"33.10","spread":"6.90"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"39.10","spread":"13.48"},{"groupId":"OG001","value":"38.30","spread":"13.49"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"41.90","spread":"6.57"},{"groupId":"OG001","value":"41.30","spread":"6.72"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"38.10","spread":"9.42"},{"groupId":"OG001","value":"36.70","spread":"8.75"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"42.40","spread":"7.26"},{"groupId":"OG001","value":"42.80","spread":"7.37"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"37.10","spread":"11.71"},{"groupId":"OG001","value":"35.50","spread":"11.39"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"39.30","spread":"11.25"},{"groupId":"OG001","value":"37.50","spread":"11.31"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"47.50","spread":"10.30"},{"groupId":"OG001","value":"45.00","spread":"10.73"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"42.50","spread":"5.10"},{"groupId":"OG001","value":"42.80","spread":"5.15"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"48.20","spread":"5.58"},{"groupId":"OG001","value":"48.80","spread":"5.15"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"33.30","spread":"6.13"},{"groupId":"OG001","value":"32.30","spread":"5.83"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"41.20","spread":"13.44"},{"groupId":"OG001","value":"38.80","spread":"13.48"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"41.90","spread":"6.20"},{"groupId":"OG001","value":"42.00","spread":"6.80"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"41.70","spread":"9.04"},{"groupId":"OG001","value":"40.10","spread":"8.60"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"42.10","spread":"6.89"},{"groupId":"OG001","value":"41.60","spread":"6.46"}]}]}]},{"type":"SECONDARY","title":"11-point Likert Pain Scale","description":"The 11 point Likert pain scale which used a 0 (no pain) to 10 (worst possible pain) point rating system was used to assess participant's pain score. No distinction was made between neuropathy and inflammatory (nociceptive) pain.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.20","spread":"2.76"},{"groupId":"OG001","value":"4.50","spread":"2.83"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.10","spread":"2.27"},{"groupId":"OG001","value":"2.50","spread":"2.54"}]}]}]},{"type":"SECONDARY","title":"Transcutaneous Local Tissue Oxygenation (pO2)","description":"Transcutaneous pO2 was assessed at the dorsum of the foot in the first intermetatarsal space using an appropriately calibrated instrument. The skin oxygen partial pressure was determined by measuring the oxygen reduction current by means of a measuring cell.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"31.80","spread":"21.29"},{"groupId":"OG001","value":"36.00","spread":"17.11"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"38.80","spread":"19.58"},{"groupId":"OG001","value":"39.70","spread":"16.18"}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Number of All Hemorrhages","description":"Major hemorrhages: defined as fatal bleeding, clinically overt bleeding causing a fall in hemoglobin more than or equal to 20 gram (g)/litre (L) (2 g/ decilitre \\[dL\\]), clinically overt bleeding leading to transfusion of more than or equal to 2 units of whole blood or red cells, or symptomatic bleeding in areas of special concern (intracranial, retroperitoneal, intraocular, intraspinal, pericardial, intramuscular with compartmental syndrome, or intraarticular). Minor hemorrhages: defined as bleeding that did not meet the definition of major bleeding.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"10","spread":null},{"groupId":"OG001","value":"2","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Number of Major and Minor Hemorrhages","description":"Major hemorrhages: defined as fatal bleeding, clinically overt bleeding causing a fall in hemoglobin more than or equal to 20 gram (g)/litre (L) (2 g/ decilitre \\[dL\\]), clinically overt bleeding leading to transfusion of more than or equal to 2 units of whole blood or red cells, or symptomatic bleeding in areas of special concern (intracranial, retroperitoneal, intraocular, intraspinal, pericardial, intramuscular with compartmental syndrome, or intraarticular). Minor hemorrhages: defined as bleeding that did not meet the definition of major bleeding.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8","spread":null},{"groupId":"OG001","value":"2","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Number of Clinically Relevant Minor Hemorrhages and Trivial Hemorrhages","description":"Clinically relevant minor (non-major) bleeding was defined as any bleeding compromising hemodynamics, leading to hospitalization, subcutaneous haematoma more than 25 cm\\^2, intramuscular haematoma, epistaxis lasting for more than 5 minutes, spontaneous gingival bleeding, macroscopic hematuria and gastrointestinal hemorrhage (including at least 1 episode of melaena or hematemesis), rectal blood loss, hemoptysis, and any other bleeding with clinical consequences. Trivial bleeding was defined as all minor bleeding that did not meet the definition of clinically relevant minor bleeding.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":33,"n":184},"commonTop":["Skin ulcer","Infected skin ulcer","Injection site haematoma","Ulcer","Pain in extremity"]}}}